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Abstract: Over the last decade, proanthocyanidins (PACs) are attracting attention not only from the
food industry but also from public health organizations due to their health benefits. It is well-known
that grapes are a good source of PACs and for that reason, the industry is also focused on grape
by-products identification and bioactivity evaluation. Grape seeds extract (GSPE) is a rich source
of PACs, mainly composed of monomeric catechin and epicatechin, gallic acid and polymeric and
oligomeric proanthocyanidins. Thus, this review encompasses the state-of-art structure and the
most recent evidence about the impact of GSPE on chronic diseases, with a focus on oxidative
stress, inflammation and metabolic syndrome (MeS)-related disorders such as obesity, diabetes and
cardiovascular risk disease in vivo to offer new perspectives in the field that allow further research.
Despite the controversial results, is undeniable that PACs from grape seeds are highly antioxidants,
thus, the capacity of GSPE to improve oxidative stress might mediate the inflammation process and the
progress of MeS-related pathologies. However, further well-design animal studies with standardized
dosages and GSPE composition are necessary to shed light into the cause-effect relationship in a more
accurate way to later allow a deeper study of the effect of GSPE in humans.
Keywords: grape seed by-products; proanthocyanidins; metabolic syndrome; chronic diseases;
in vivo animal studies
1. Introduction
Plant-derived natural products are being actively investigated as health promotors due to their
composition in bioactive compounds. Within those bioactive compounds, phenolic compounds
represent one of the most interesting group. These biomolecules represent a wide group of secondary
plant metabolites playing a crucial role in counteracting various type of stress (ultraviolet irradiation,
aggression by pathogens, parasites and plant predators), other than contributing to organoleptic
properties of plants and plant-derived food [1,2]. The variety and the high number of compounds
from this group is well-known. Proanthocyanidins (PACs), also known as condensed tannins, are
spread over the plant kingdom, including fruits, seeds of some plants, flower, nuts or barks. They can
be easily found in fruits such as berries or grapes, among others and also in tea, cocoa, chocolate, wine,
peanut, almond and avocado or some cereals, among other sources [3,4].
Over the last decade, plant and food-derived PACs are attracting attention not only from the food
industry but also from public health organizations due to their ability to prevent chronic diseases [5–7].
As examples of the effect of PACs from different matrices is not difficult to find studies regarding
juices, syrup and extract cranberry-derived PACs which demonstrated to be effective in the prevention
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of urinary tract infection in vivo and in vitro [8–10]; proanthocyanidins from blueberry-blackberry
fermented beverages that showed high antioxidant and anti-inflammatory activity in vitro [11]; or
PACs from a persimmon leaf tea that suggested their antihypertensive effect in animal models [12].
More specifically, PACs from grape seeds have shown a broad pharmacological and therapeutic
health effects against cardiovascular disease (CVD), diabetes mellitus, obesity or cancer which are
related with oxidative stress and inflammatory processes [13,14]. However, the extensive literature
available mainly focused on in vitro and in vivo animal models studies, make difficult to have an
overview focused on the health effect of grape seed proanthocyanidins. Thus, the aim of this review is
to encompass the most recent evidence regarding the in vivo bioactivity of PACs from grape seeds. For
that purpose, METLIN and Scopus electronic databases have been employed including literature from
the last 10 years related to the effect of grape seeds PACs on oxidative stress, inflammation, obesity,
diabetes and cardiovascular risk disease in animal models.
2. Composition and Content of Proanthocyanidins in Grape Seeds and Grape Seed Extracts
Winery and grape juice industries produce large amounts of by-products (grape pomace) that are
represented by skins, stems and seeds [15]. Grape pomace corresponds to the 20% w/w of grape weight
and grape seeds constitute until the 52% (w/w) of grape pomace [16,17].
Winery and grape juice by-products are a source of phenolic compounds with demonstrated
antioxidant and antimicrobial activities [16]; because of that, their revalorization has recently become
an area of growing interest [14]. In fact, a considerable amount of available works is focused on the
determination of the composition in bioactive compounds of grape by-products such as phenolic
compounds. The main grape seeds phenolic compounds include anthocyanins, flavan-3-ols, flavonols,
stilbenes, and phenolic acids [18]. Recently, Tang and co-workers [19] noticed that the total flavonoid
content in grape seeds is up to ten times higher than grape peel, thus, reinforcing the importance of
this grape by-product.
On its behalf, phenolic acids are represented by hydroxybenzoic and hydroxycinnamic derivatives;
the most representative of the first class are gallic and protochatechuic acid ranging from 6.5 to 224.0
and from 2.0 to 10.0 µg/g d.w., respectively [17]. The most abundant hydroxycinnamic acids are
chlorogenic, caftaric and caffeic acid followed by trans-coutaric acid and their content varied from
0.4 to 68 µg/g d.w. [17]. However, ellagic acid derivatives and protocatechuic aldehyde were also
determined in enriched grape seed extracts [15].
About flavonols, quercetin and kaempferol derivatives are the most important [15,17,20];
moreover, luteolin and dihydrofisetin derivatives are the most representative flavones [15,16,21]
while cyanidin-3-glucoside is the principal anthocyanin determined in grape seed and its content was
0.058–0.840 mg/g f.w. [18].
Thanks to the protection against oxidative stress, particular attention was paid to grape seed
flavan-3-ols compounds including catechin and epicatechin monomers and their respective oligomers
in galloylated and no galloylated form namely proanthocyanidins [22–24]. Proanthocyanidins included
oligomers and polymers of flavan-3-ol units [25]. According to De Freitas et al. [26], grape seeds
contain B-type proanthocyanidins in their galloylated and no-galloylated form. Thus, the flavan-3-ols
monomers are singly linked through C4→C6 or C4→C8 bonds [27] (Figure 1).
Nutrients 2019, 11, 2435 3 of 18
Nutrients 2019, 11, x FOR PEER REVIEW 3 of 20 
 
 
Figure 1. Structural presentation of B-type proanthocyanidin units. 
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mg/g of seed d.w. and that monomers (catechin and epicatechin) and polymers were the most 
abundant. Travaglia et al. [29] determined that the mean of proanthocyanidins content in seeds of 37 
grape cultivars was 159 mg/g of seed. Escribano-Bailon and co-workers [30] documented that the 
abundance of PACs in grape seeds are in the following order: (+)-catechin > (-)-epicatechin>(-)-
epicatechin-3-O-gallate > epicatechin 3-O-gallate-(4→8)-catechin (B1-3-O-gallate)>epicatechin-(4→8)-
epicatechin (dimer B2). 
Fuleki and Ricardo da Silva [31] characterized 11 flavan-3-ols in the seeds of 17 grape cultivar 
showing them (+)-catechin and (−)-epicatechin are the main flavan-3-ols compounds followed by, 
procyanidin B1, B2, B3, B4, B1-3-O-gallate, B2-3-O-gallate, B2-3‘-O-gallate, and C1. 
Bombai and co-workers [32] determined the monomers, oligomers from dimers to dodecamers 
and polymers. They noticed that monomers are the most concentrated flavan-3-ols in cv. Sangiovese 
seeds, followed by dimers, trimers and polymers and they found that their concentration was 
strongly influenced by the ripening. Moreover, Genebra et al. [33] found that the irrigation regime 
influences the proanthocyanidin biosynthetic pathway more than the genes responsible for their 
synthesis. 
Montero and co-workers [34] also characterized the grape seed proanthocyanidins by 2D-LC-
MS identifying from monomers to heptamers and polymers in grape seeds from cv. Malvar. 
Several approaches were used to collect the proanthocyanidin compounds from grape seeds. 
Conventionally, organic solvents are used, however, the recoveries are low and unsustainable, thus, 
advanced green extraction technologies followed by a concentration/purification step are used to 
produce the extracts for food and health scope [14]. Among others, enzymatic treatment, pulsed 
electric fields, microwave-assisted extraction, ultrasound-assisted extraction, and supercritical and 
subcritical fluid extraction are the most studied techniques. However, the industrial application is 
not still possible for all of them [14,35]. Additionally, it should be mentioned that the 
concentration/purification step could be carried out by exchange resins purification or by membrane 
filtration [15,36,37]. 
Kuhnert et al. [38] analyzed several commercial grape seed extracts by HPLC-FLD and 
determined a total content of proanthocyanidins ranging from range of 76 to 99%. Polymers (with 
degree of polymerization > 5) varied from 47 to 81% (w/w), monomers and dimers were 7–14% (w/w), 
and galloylated monomers and dimers, trimers and tetramers ranged from 0 to 5.3% (w/w). Before 
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used to determine the total content of proanthocyanidins in grape seed extracts, gives very different
results if compared to the HPLC method. Thus, this aspect should be strongly taken into account when
standardized grape seed extracts were bought and used to evaluate their in vivo activities.
3. Biological Activities of Proanthocyanidins from Grape Seeds
3.1. Oxidative Stress
Oxidative stress has been defined as loss of balance between the oxidative and anti-oxidative
systems of the cells and tissues producing over production of reactive oxygen species (ROS) [39].
dual-faceted molecules able to influence various physiological cellular processes at modest levels
and cause severe oxidative damage to cell components at high levels [40]. It is well known that
this imbalance condition plays a crucial role in the pathogenesis of several human diseases such as
atherosclerosis, diabetes, hypertension or cancer, among others [12,13,38,41]. In this context, grape
seeds proanthocyanidins have demonstrated to be more powerful free radical scavengers than vitamins
C, E and β-carotene in vitro and in vivo [13]. A large number of new studies focused on evaluating the
role of GSPE against oxidative stress are emerging. Some of the most recent findings are summarized
in Table 1.
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Table 1. Effect of proanthocyanidins from grape seeds on oxidative stress in animal models.
GSPE Extract Composition GSPE Purity * Dose Study Design Major Outcomes Reference
Oxidative stress
NE 99% 400 mg/kg BW/day
Fluoride-induced iron overload
Kunming male mice; GSPE (5
weeks)
↓ ALT, AST, MDA, iron content; ↑
GSH-Px, SOD, T-AOC [42]
54% dimeric, 13% trimeric procyanidins, and 7% tetrameric
proanthocyanidins NE 100 mg/kg BW
Cd intoxicated-adult male albino
Wistar rats; GSPE (4 weeks)
↓ ROS, TBARS, LOOH, PC, CD, and
NO, ↑ GSH, TSH, Vitamin C and E [43]
Dimer (56%), trimer (12%), tetramer (6.6%), monomers and other
high-molecular mass oligomers (20.4%) >95% 100 and 300 mg/kg BW
HFD fed male Sprague Dawley rats;
GSPE (13 weeks)
↓MDA levels and ↑ GSH, GSH-Px and
SOD activities of the testes tissue [44]
NE ≥95% 1, 50 and100 mg/kg BW/day Male ICR mice; GSPE (28 days)
↑ T-AOC, SOD, CAT and ↓MDA
activities in plasma and in skeletal
muscle (50 and 100 mg/kg BW day
of GSPE)
[45]
54% dimeric, 13% trimeric and 7% tetrameric proanthocyanidins NE 100 mg/kg BW/day Cd-intoxicated male albino Wistarrats; GSPE (4 weeks)
↓ AST, ALT, ACP, LDH and ΥGT and ↑
ALP; ↓ TBARS, LH, NO plasma levels
and ↑ vitamins C and E and GSH
plasma concentration
[46]
NE >95%
High dose
400 mg/kg BW/day, 100,
200, 400 mg/kg BW/day
As-induced Oxidative
Reproductive Toxicity male
Kunming mice; GSPE (5 weeks)
GSPE (400 mg/kg/BW) ↓MDA and
8-OHdG levels and ↑ T-AOC, GSH and
SOD activities
[47]
56% dimeric, 12% trimeric procyanidins, and 6.6% tetrameric PACs NE 200 mg/kg BW/day Pb-induced lung toxicity maleWistar rats, GSPE (5 weeks)
↓MDA levels and total Pb
accumulation in the lung. ↑ GSH, SOD,
γ-GCS activities and Nrf2 levels in
lung tissue
[48]
Flavan-3-ols (21.3%), dimers (17.4%), trimers (16.3%), tetramers (13.3%)
and oligomers (5–13 units; 31.7%) of PACs >75% 375 mg/kg BW/day
Male, spontaneously hypertensive
rats, GSPE (2 days)
No changes in MDA liver tissue and
plasma ACE, ↑ GSH [49]
NE 37% 100 mg/kg BW/day
Hypercholesterolemic
induced-male Wistar rats; GSPE (30
days)
↑ SOD, CAT, GSH, ascorbate and α
-tocopherol in cardiac tissue [50]
NE NE 150, 240,384 mg/kg BW/day
DOCA hypertension-induced SD
rats; GSPE (4 weeks)
↑ SOD activities, inhibition of the
increase of serum and cardiac tissue
MDA, inhibition of p-JNK1/2 and
p-p38MAPK
[51]
Catechin (58 mol/g), epicatechin (52 mol/g), epigallocatechin
(5.50 mol/g), epicatechin gallate (89 mol/g), epigallocatechin gallate
(1.40 mol/g), dimeric procyanidins (250 mol/g), trimeric procyanidins
(15.68 mol/g), tetrameric procyanidins (8.8 mol/g), pentameric
procyanidins (0.73 mol/g), and hexameric procyanidins (0.38mol/g)
>75% 35 mg/kg BW/day Obese Zucker rats; GSPE (10weeks)
↑ GSH/GSSG ratio and ORAC, ↓
GSSG content [52]
* NE, non-specified; ACE, plasma angiotensin-converting enzyme activity; ALP, alkaline phosphatase; AST, aspartate aminotransferase; BW, body weight; CAT, catalase; CD, Conjugated
dienes; γ-GCS, γ-glutamyl cysteine synthetase; GSH, glutathione reduced; GSH-Px, glutathione peroxidase; GSPE, grape seed proanthocyanidins extract; GSSG, Glutathione disulphide;
γGCS, γ-glutamate-cysteine ligase; γGT, gamma-glutamyl transferase; HFD, high-fat diet; LDH, lactate dehydrogenase; LOOH, lipid hydroperoxides; MDA, malondialdehyde; NO, nitric
oxide; 8-OHdG, 8-hydroxy-2′-deoxy guanosine; ORAC, oxygen radical absorbance capacity; p38MAPK, p38 mitogen-activated protein kinases; PACs, proanthocyanidins; PC, protein
carbonyls; p-JNK1/2, JNK1/2 phosphorylation; SOD, superoxide dismutase; T-AOC, total antioxidant capacity; TBARS, thiobarbituric acid reactive substances.
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Oxidative stress is also related to male infertility through sperm dysfunction caused by an increase
of oxygen and oxygen-derived free radicals i.e., ROS [44]. In addition, it has been demonstrated that
As and Cd exposition reduces male fertility by peroxidative damage to the plasma membrane [43,47].
In this context, a recent study showed that a dosage of 100/mg/kg BW of GSPE significantly decreased
the oxidative stress markers i.e., thiobarbituric acid reactive substance (TBARS), lipid hydroperoxides
(LOOH), protein carbonyls (PC), conjugated dienes (CD), and nitric oxide in Cd-induced testes-toxicity
rats when administering for 4 weeks [43]. Authors also found a significant decrease of ROS when the
extract was employed alone as a treatment and when it was pre-administrated to Cd-treated rats [43,46].
The supplementation with 400 mg/kg/BW of GSPE showed to block As-induced pathological changes
and oxidative damage in rats by significantly reducing MDA and 8-OHdG levels and increasing the
T-AOC, GSH and SOD activities [47]. In the same line, dosages of 100 and 300 mg/kg BW of GSPE
administered to a high-fat diet fed male Sprague Dawley rats significantly decreased malondialdehyde
(MDA) levels and increased the glutathione reduced (GSH); glutathione peroxidase (GSH-Px) and
superoxide dismutase (SOD) activities of the testes tissue, thus, ameliorating HFD-induced testicular
toxicity [44].
Cadmium, together with lead, is one of the most relevant heavy metals which have demonstrated to
disrupt the balance of the body’s antioxidant system by reducing the activities of antioxidants enzymes
which can induce apoptosis [53]. A clear alteration of several oxidative stress parameters i.e., an increase
of MDA levels and a significant decrease of GSH, SOD and γ-GCS activities and the levels of Nrf2 in lung
tissue were found in Pb-induced lung toxicity male Wistar rats [48]. However, those parameters were
significantly reversed by administering 200 mg/kg BW/day of GSPE for 5 weeks which also decreased the
total Pb concentrated in the lung and reduced Pb-induced apoptosis [48]. Moreover, Cd stimulates the
formation of metallothioneins and ROS in red blood cells and lymphocytes, thus, inducing erythrocyte
apoptosis which can produce anemia [46]. In this regard, Nazima et al. showed that when rats were
intoxicated with Cd, the activities of the plasma biomarkers enzymes such as AST, ALT, ACP, LDH and
ΥGT increased and ALP activity decreased when comparing to control group. The same trend was found
with non-enzymatic antioxidants i.e., TBARS, LH and NO plasma levels that increased in Cd-treated rats
in which vitamins C, vitamin E and GSH significantly decreased [46]. Once again, the supplementation
GSPE (100 mg/kg BW/day) for 4 weeks significatively prevented the abovementioned impairment, thus,
providing protection against Cd-induced oxidative damage in rat erythrocytes [46].
Chronic fluoride intoxication could cause toxicity to the liver [42]. In this regards, earlier research
demonstrated that iron overload is implicated in fluoride-induced oxidative damage in vitro attenuated
by GSPE which protected the cells against oxidative stress [42]. A more recent study showed that
400 mg/kg BW/day of GSPE significantly decreased levels of ALT, AST, MDA and iron content
in liver tissue and increased the GSH-Px, SOD, T-AOC levels in fluoride-induced iron overload
Kunming male mice [42]. Despite the mechanism involved in the GSPE liver protection related to
fluoride-mediated hepatic oxidative damage is not being fully elucidated, proanthocyanidins from
grape seeds have iron-chelating effects that can prevent the production of free radicals normally caused
by iron overload [42].
Apart from the protection against oxidative stress induced by metals, medium doses of GSPE (50
and 100 mg/kg BW/day) have also demonstrated anti-fatigue effects in exhaustive exercise-induced
fatigue mice by increasing T-AOC, SOD, CAT activities and preventing MDA levels in plasma and
skeletal muscle [45]. However, despite at higher doses of 375 mg/kg BW/day, GSPE increased the
activity of GSH-Px, no significant changes in MDA liver tissue and plasma ACE were found in
spontaneously hypertensive rats [49]. Even so, author highlighted the protective role of GSPE against
oxidative stress due to the fast increase of hepatic GSH in treated rats after 6 h post administration [49].
Obesity and related complications such as hypercholesterolemia are linked with higher
susceptibility to oxidative stress due to a depletion of antioxidant components such as SOD, GPx, CAT
and some vitamins i.e., vitamin A, E, C and β-carotene [50]. Low doses of GSPE (35 mg/kg BW/day)
administered for 10 weeks, have also showed an improvement of the hepatic oxidative status in obese
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Zucker rats through the increment of GSH/GSSG ratio and ORAC and a decrease of GSSG content [52].
Thiruchenduran et al. found a significant increase in SOD, CAT, GSH, ascorbate and α -tocopherol in
cardiac tissue from hypercholesterolemic induced-male Wistar rats even with a lower purity extract
(37% of PACs) compared to the extracts employed in the other studies [50]. Therefore, PACs from grape
seeds decreased lipid peroxidation (LPO) by the chelation of the ROS and increasing the antioxidant
defense system [50].
The current literature agrees about the potential protective effect against oxidative stress of GSPE
when administered between 35 and 400 mg/kg BW/day in vivo in animal studies. The most recognized
mechanism of action resides in the inhibition of lipid peroxidation, avoiding the ROS production, and,
therefore, saving cell membranes to apoptosis.
3.2. Inflammation
It is not new that flavonoids play an important role in the immune system and, thus, in the
inflammatory processes like those related with metabolic syndrome (MeS) such as diabetes, obesity and
cardiovascular diseases which are closely associated with inflammatory process [54]. More specifically,
PACs from grape seeds were early highlighted to possess anti-inflammatory effects in animal models
mainly by inhibiting the formation of pro-inflammatory cytokines [55]. Moreover, it is well-known
that a decrease in oxidative stress reduces the inflammatory response but also recent studies have
shown that PACs can reduce inflammation in a more direct way as reviewed by Weseler et al. [56].
Table 2 encompasses the latest in vivo studies related to the effect of GSPE on inflammation. It can
be seen that doses from 1 to 500 mg/kg BW/day employing extracts from 75 to 95% purity have been
tested with promising results.
Several adipokines such as leptin, interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-α), adipsin,
resistin and angiotensinogen/PAI-1, and adiponectin, among others are recognized as mediators of
inflammation [57]. In inflammation, leptin acts directly on macrophages increasing proinflammatory
cytokine production which can be reduced by GSPE [58]. In this context, Terra et al. found that a dose of
345 mg/kg BW/day of GSPE containing mainly oligomeric PACs (31.7%) significantly decreased plasma
C-reactive protein (CRP) and increased adiponectin plasma concentrations in male Zucker rats fed with
high-fat diet for 19 weeks. Additionally, they found that PACs from grape seed extract modulated the IL-6,
TNF-α and adiponectin gene expression in adipose tissue, thus, reducing the diet-induced low-grade
inflammation [59]. Interestingly, lower doses of GSPE (20 mg GSPE/animal/day) for a short period of
time (10 days) also reduced cytokine expression in liver, muscle and mesenteric adipose tissue [60].
Low doses (20 mg/kg BW GSPE/day) have been administered as part of a preventive treatment in
HFD-fed female Wistar rats allowing a significant decrease of CRP, TNF-α, and IL-6 and increasing the
anti-inflammatory cytokine adiponectin expression in adipose tissue [58]. A chronical treatment (7 weeks)
consisted of 300 mg/kg/BW day of 95% pure GSPE decreased plasma levels of TNF-α, IL-6 and monocyte
chemotactic protein 1 (MCP-1) which facilitates the accumulation of macrophages [61]. Nevertheless,
GSPE has proved to have anti-inflammatory effects not only at adipose tissue level but also in the intestine,
skeletal muscle and lung tissue. At dosages of 100 and 500 mg/kg BW/day, GSPE ameliorated intestinal
health in diet-induced obese rats by reducing the proinflammatory cytokine TNF-α secretions to basal
levels, reducing transepithelial electrical resistance in small and large intestine and reverting plasma
bacterial endotoxins such as lipopolysaccharides to basal levels [62]. Additionally, a down regulation
of inflammatory factors such as myeloperoxidase, IL-1β, IL-6 and TNF-α in lung tissue of pulmonary
arterial hypertension-induced rats treated with 10 mL/kg BW/day of intraperitoneal 99.5% purity-grape
seed proanthocyanidins have been observed [63]. A significant reduction of the expression of TNF-α in
the lung was also described when 200 mg/kg BW/day were administered to Pb-induced lung toxicity
male Wistar rats [48]. A recent study carried out in mouse model of exhaustive exercise-induced fatigue
that treated the animals with GSPE concentrations from 1 to 100 mg/kg BW/day, revealed that medium
doses i.e., 50 and 100 mg/kg BW/day reduced TNF-α and IL-1β activities in plasma and in skeletal muscle,
thus, improving exhaustive exercise [45].
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Table 2. Effect of proanthocyanidins from grape seeds on inflammation in animal models.
GSPE Extract Composition GSPE Purity* Dose Study Design Major Outcomes Reference
Inflammation
NE >95% 300 mg/kg BW/day
Specific-pathogen free male
C57BL/6 mice fed with HFD;
GSPE (7 weeks)
↓ Plasma levels of TNF-α, IL-6 and
MCP-1 [61]
Flavan-3-ols (21.3%), dimers (17.4%),
trimers (16.3%), tetramers (13.3%) and
oligomers (5–13 units; 31.7%) of PACs
>75% 345 mg/kg BW/day HFD fed male Zucker rats; GSPE(19 weeks)
↓ CRP, ↑ adiponectin plasma levels,
no differences in IL-6 plasma levels [59]
Flavan-3-ols (21.3%), dimers (17.4%),
trimers (16.3%), tetramers (13.3%) and
oligomers (5–13 units; 31.7%) of PACs
>75% 30 mg/kg BW/day HFD fed female Wistar rats; GSPE(15 weeks) - Preventive treatment
↓ CRP and TNF-α plasma and
adipose tissue levels, ↓ IL-6, Emr1
and ↑ adiponectin in adipose tissue
[60]
Flavan-3-ols (21.3%), dimers (17.4%),
trimers (16.3%), tetramers (13.3%) and
oligomers (5–13 units; 31.7%) of PACs
>75% 10 or 20 mg/animal/day Diet-induced obese female Wistarrats; GSPE (10 days or 30 days)
↓ CRP and TNF-α plasma levels after
10 days (20 mg/animal/day) [60]
Flavan-3-ols (21.3%), dimers (17.4%),
trimers (16.3%), tetramers (13.3%) and
oligomers (5–13 units; 31.7%) of PACs
>75% 100 and500 mg/kg BW/day
Diet-induced obese female Wistar
rats; GSPE (2 weeks)
↓ TNF-α secretions, ↓ transepithelial
electrical resistance in small and large
intestine, ↓ plasma LPS to basal levels
[62]
56% dimeric, 12% trimeric procyanidins,
and 6.6% tetrameric PACs NE 200 mg/kg BW/day
Pb-induced lung toxicity male
Wistar rats, GSPE (5 weeks)
↓ inflammatory cells in the lung
tissue, ↓ TNF-α in lung tissue [48]
NE ≥95% 1, 50 and100 mg/kg BW/day Male ICR mice; GSPE (28 days)
↓ TNF-α and IL-1β activities in
plasma and in skeletal muscle (50
and 100 mg/kg BW day of GSPE)
[45]
NE 99.5 g GSP/mL 10 mL/kg BW/day
Monocrotaline-induced PAH
male Sprague–Dawley rats; GSPE
(3 weeks)
Down regulation of myeloperoxidase,
IL-1β, IL-6 and TNF-α in lung tissue [63]
* NE, non-specified; BW, body weight; CRP, C-reactive protein; Emr1, mucin-like hormone receptor 1; GSP, grape seed proanthocyanidins, GSPE, grape seed proanthocyanidins extract; IL,
interleukin; LPS, lipopolysaccharides; MCP-1, monocyte chemoattractant protein 1; PACs, proanthocyanidins; PAH, pulmonary arterial hypertension; TNF-α, tumor necrosis factor alpha.
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Even more studies are necessaries, the aforementioned results reinforce the potential of GSPE
as anti-inflammatory natural extract capable to downregulate pro-inflammatory cytokines and to
increase the expression of the anti-inflammatory ones even at low dosages and using GSP extracts with
different composition.
3.3. Metabolic Syndrome-Related Disorders
Metabolic syndrome was defined by the World Health Organization (WHO) as a condition that includes
abdominal obesity, insulin resistance, hypertension, and hyperlipidemia [64]. The prevalence of MeS is
increasing and its prevention has to be multifactorial starting with the change of dietary habits. Since this
is a long-term arduous task, several strategies that include the use of pharmaceutical o dietary agents are
being tested. In this regard, PAC-rich products e.g., GSPE, berries or Hibiscus sabdariffa extract have proved
to have anti-obesity effects and/or to improve fatty acid oxidation and insulin responses [65,66]. Concretely,
the latest literature focused on the effect of GSPE on metabolic syndrome-related disorders i.e., obesity,
diabetes mellitus and cardiovascular risk disease is summarized in Table 3.
3.3.1. Obesity
Obesity increases adipose burden but also alters adipose biology [64]. Proanthocyanidin rich
extracts have proved to be involved in obesity modulation through the suppression of food intake
and the increase of energy expenditure [63]. In this regard, a recent research concluded that GSPE is
capable to modulate the enteroendocrine system in cafeteria-diet-fed rats in which also reduced the
BW and food intake at 500 mg/GSPE kg BW per day chronically (17 weeks) [67]. Serrano et al. found
that a minimum dose of 350 mg/kg BW was necessary to observe food intake reduction of rats fed
with standard chow after an acute oral GSPE treatment [68]. Contrarily, the authors reported that
higher doses of GSPE (500 to 1000 mg/kg BW/day) were necessaries for getting an effective effect under
a chronic treatment. They found that 79% of food intake could be explained by the hypothalamic
glucagon-like peptide 1 expression [68] which has demonstrated to be one of the most promising
biological systems related to obesity prevention or treatment [69].
Doses of 345 mg/kg GSPE BW did not influence BW nor adiposity index in HFD-fed Zucker
rats [59]. The employed extract was mainly constituted by oligomeric procyanidins (31.7%) followed
by monomeric (21.3%), dimeric (17.4%), trimeric (16.3%), tetrameric (13.3%). In agreement, a recent
research did not show any change in adiposity at 500 mg/kg BW but they found a significantly decrease
of BW in diet-obese Wistar rats using the extract with the same composition [62]. Epidermal fat mass
was also reduced in specific-pathogen free male C57BL/6 mice fed with HFD with a >95% purity GSPE
extract for 7 weeks without having any effect in BW [61]. Lower doses (300 mg/kg BW) of a GSPE
mainly consisted of PAC dimers (56%) also allowed a significant decrease in relative weight of white
adipose tissue (WAT) in HFD-fed Sprague Dawley rats [44].
Nevertheless, the mechanism underlying the anti-obesity effect of grape seed PACs has not been
fully-elucidated. Margalef et al. concluded that the tissue-detected compounds after the administration
of GSPE come from an acute GSPE administration and not from a long-term accumulation [70]. In
this regard, the administration of 500 mg/kg BW/day intermittently allowed a significant reduction of
diet-induced obese Wistar rats BW [71]. Contrarily, the administration of lower doses of the studied
extract i.e., 100 mg/kg BW/day for longer periods of time (30 days) significantly decreased the BW in
hypercholesterolemic induced-male Wistar rats [50]. In a more recent study, a significant decrease in
food intake accompanied by an increase of energy expenditure in subcutaneous adipose tissue was
found in aged male Wistar rats after a sub-chronic intake of 500 mg/kg BW/day for 8 days [71]. Since
most of the GSPE have similar but not identical composition, the only factor that seems to be more
related to BW decrement could be the employed dose. According to the latest research, the lowest
doses employed i.e., 10 or 20 mg/animal/day and 25 mg/kg BW did not show any effect in BW reduction
in diet-induced obese Wistar rats [60,72–74]. Together with the lack of BW decrement at lower dosages,
no significant changes in adiposity index were found in the abovementioned studies. Contrarily,
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a significant reduction of the adiposity index in hamsters fed with an HFD in which similar dosages
(25 mg/kg BW/day GSPE) were employed [75]. Interestingly, Montagut et al. showed a significant
reduction on the total amount of visceral adipose tissue using the same dose (25 mg/kg BW/day of
GSPE) [72]. It has been shown that the dysregulation of signaling pathway in adipose tissue are
associated with insulin resistance that can contribute to the development of obesity-related metabolic
disorders [76]. In this regard, Montagut et al. showed GSPE modulated representative markers of
mature adipocyte such as Glut4, Srebp1c, Pparg2 after 10 days, presenting a strong down-regulation
of those genes after 30 days in induced-obese rats that was stronger at doses of 50 mg GSPE/kg
BW/day [72]. On its behalf, Pascual-Serrano exhibited a reversion of adipocyte hypertrophy by a
decrease in adipocyte size in visceral WAT [59]. In agreement, a significant reduction of the weight of
the WAT depots in hamster fed with a high-fat diet was reported by Caimari et al. [75].
Grape seed proanthocyanidins extract has also proved to be effective anti-obesity effect at low
doses when employed as a preventive treatment. Thus, 30 mg/kg BW/day allowed a significant
decrease of BW gain when administered for 15 weeks to HFD fed female Wistar rats [60]. Higher
concentrations (100 and 300 mg/kg BW) also demonstrated having a protective effect in body weigh
increase in HFD-fed male Sprague Dawley rats [44]. There are still discrepancies about the best
employed GSPE-based treatment against obesity but some authors suggest that the effectiveness of
GSPE supplementation would depend on the initial amount of adipose depots being less effective if
the initial adipose tissue is too high [77].
Despite the existing discrepancies regarding the effects of GSPE on fat and body weight, most of
the studies have shown an amelioration of the obesity status in vivo when proanthocyanidins from
grape seeds were administered. However, the dosage needs to be standardized. In fact, Serrano et al.
reinforced the idea that upper effective limit also needs to be also established since they found
undesirable effects when GSPE was administered at 1 g/kg BW [68].
3.3.2. Diabetes
As abovementioned, diabetes is closely linked to obesity. In fact, excess accumulation of visceral
fat is a high risk for insulin sensitivity. Thus, the prevention of obesity would be directly related to a
lower risk of diabetes [64]. Moreover, impaired homeostasis in diabetes mellitus is related to higher
production of ROS, consequently, depleting the oxidative stress status. In fact, the long-term oxidative
stress caused by hyperglycemia can induce bladder dysfunction that can be prevented administering
GSPE (250 mg/kg BW day for 8 weeks) mainly made up 56% dimeric proanthocyanidins, 12% trimeric
proanthocyanidins, 6.6% tetrameric proanthocyanidins [78].
Commercial extracts of proanthocyanidins from grape seeds made up monomeric (21.3%), dimeric
(17.4%), trimeric (16.3%), tetrameric (13.3%) and oligomeric procyanidins (31.7%) and phenolic acids (4.7%)
has been the most employed extract in animal experimental models at doses from 25 to 345 mg/kg BW/day
GSPE (Table 3). Low doses of grape seed extract (25 mg/kg BW/day) improved the insulin resistance indexes
HOMA-IR, QUICKI and R-QUICKI and the plasma glucose and insulin levels in diet-induced obese male
Wistar rats after 3 weeks of treatment [73]. In agreement, the same dose, significantly decreased fasting
plasma insulin levels after 10 and 30 days [72]. Higher doses (375 mg/kg BW) also improved significantly
the glucose levels in HFD-fed male Zucker rats reducing the glucose levels by 14% [59]. Additionally,
the treatment with a different extract composition i.e., 96.64% purity GSPE increased in a significant way
the normal insulin content and also the score of beta-cell function and the abnormal oral glucose tolerance
were partially reversed [76]. The beta-cell function is involved in folding, export and processing of newly
synthesized insulin. The proposed mechanism for which GSPE could avoid beta-cells dysfunction and
death in T2DM might be through the decrease of oxidative stress of the endoplasmic reticulum [79]. Those
effects could be likely due to the modification of anti-apoptotic markers in the pancreas in animals’ models
under altered conditions [80]. Contrarily to the previous reported data, Pascual-Serrano et al. did not find
any significant change in glucose, insulin or HOMA-IR plasma levels in diet-induced obese Wistar rats that
were treated with different dosages up to 200 mg/kg BW of GSPE for 12 weeks [74].
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Table 3. Effect of proanthocyanidins from grape seeds on metabolic syndrome-related diseases in animal models.
GSPE Extract Composition GSPE Purity * Dose Study Design Major Outcomes Reference
Obesity
Flavan-3-ols (21.3%), dimers (17.4%), trimers
(16.3%), tetramers (13.3%) and oligomers
(5–13 units; 31.7%) of PACs
>75% 500 mg/kg BW/day Aged male Wistar rats; GSPE (8 days) ↓ Food intake, ↑ energy expenditure, ↓ BW [71]
Flavan-3-ols (21.3%), dimers (17.4%), trimers
(16.3%), tetramers (13.3%) and oligomers
(5–13 units; 31.7%) of PACs
>75%
Acute treatment
1000 mg/kg; Chronic
treatment: 500 and
1000 mg/kg BW/day
Female Wistar rats; GSPE (8 days)
Acute treatment: ↑ GLP-1 plasma levels, CART
mRNA expression; chronic treatment: no
differences in leptin levels; no clear effects on the
hypothalamic mRNA levels
[68]
Flavan-3-ols (21.3%), dimers (17.4%), trimers
(16.3%), tetramers (13.3%) and oligomers
(5–13 units; 31.7%) of PACs
>75% 100 and500 mg/kg BW/day
Diet-induced obese female Wistar rats; GSPE
(2 weeks)
No changes in adiposity, ↓ BW gain at
500 mg/kg/BW [62]
Catechin (121 ± 3 mg/g), epicatechin (93 ± 4
mg/g), PAC dimer B1 (89 ± 3 mg/g), PAC dimer
B3 (46 ± 2 mg/g)
NE 25 mg/kg BW/day Diet-induced obese male Wistar rats; GSPE(3 weeks)
↓ adipocyte size, no reduction of BW gain, no
reversion of adiposity in WAT [73]
Phenolic acids (1.63%), as well as monomeric
(20.9%), dimeric (20.7%), trimeric (17.3%) and
oligomeric (39.41%) procyanidins.
NE 25 mg/kg BW/day Male Golden Syrian hamsters fed with HFD;GSPE (15 days)
↓ Adiposity index, the weight of the WAT depots
and the BW gain [75]
Dimer (56%), trimer (12%), tetramer (6.6%),
monomers and other high-molecular mass
oligomers (20.4%)
>95% 300 mg/kg BW HFD fed male Sprague Dawley rats; GSPE(13 weeks) ↓ Relative weight of WAT [44]
NE >95% 300 mg/kg BW/day Specific-pathogen free male C57BL/6 micefed with an HFD; GSPE (7 weeks) ↓ Epidydimal fat mass, no changes in BW [61]
NE 37% 100 mg/kg BW/day Hypercholesterolemic induced-male Wistarrats; GSPE (30 days) ↓ BW [50]
Flavan-3-ols (21.3%), dimers (17.4%), trimers
(16.3%), tetramers (13.3%) and oligomers
(5–13 units; 31.7%) of PACs
>75% 25 mg/kg BW/day Diet-induced obese female Wistar rats; GSPE(10 days and 30 days)
↓ the total amount of visceral adipose tissue, no
reduction of BW gain, no changes in plasma
leptin levels after 30 days intervention
[72]
Flavan-3-ols (21.3%), dimers (17.4%), trimers
(16.3%), tetramers (13.3%) and oligomers
(5–13 units; 31.7%) of PACs
>75% 345 mg/kg BW/day HFD fed Male Zucker rats; GSPE (19 weeks) No changes in adiposity index or in BW [59]
Monomeric (21.3%), dimeric (17.4%), trimeric
(16.3%), tetrameric (13.3%) and oligomeric
(5–13 units) (31.7%) procyanidins and phenolic
acids (4.7 %)
>75% 30 mg/kg BW/day HFD fed female Wistar rats; GSPE (15 weeks)- Preventive treatment
↓ BW gain, no changes in adiposity or the
weight of fat depots [60]
Flavan-3-ols (21.3%), dimers (17.4%), trimers
(16.3%), tetramers (13.3%) and oligomers
(5–13 units; 31.7%) of PACs
>75% 10 or 20 mg/animal/day Diet-induced obese female Wistar rats; GSPE(10 days or 30 days) No significant ↓in adiposity index or in BW [60]
Flavan-3-ols (21.3%), dimers (17.4%), trimers
(16.3%), tetramers (13.3%) and oligomers
(5–13 units; 31.7%) of PACs
>75% 25 mg/kg BW Diet-induced obese male Wistar rats; GSPE(12 weeks)
No significant reduction in weight gain or
reverse or adiposity, ↓ adipocyte size [73]
Flavan-3-ols (21.3%), dimers (17.4%), trimers
(16.3%), tetramers (13.3%) and oligomers
(5–13 units; 31.7%) of PACs
>75% 25, 100 and 200 mg/kg BW Diet-induced obese male Wistar rats; GSPE(3 weeks)
Not improvement of adiposity index, prevention
in the increase of the area and volume of the
WAT, no change in leptin plasma levels, BW and
upregulation PPARΥ (200 mg/kg BW)
[74]
Monomers of flavan-3-ols (21.3%), dimers
(17.4%), trimers (16.3%), tetramers (13.3%) and
oligomers (5–13 units; 31.7%) of PACs
>75% 500 mg/kg BW/day Diet-induced obese female Wistar rats; GSPEintermittently
↓ BW, total WAT, BAT, % visceral adiposity and
% total adiposity [77]
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Table 3. Cont.
GSPE Extract Composition GSPE Purity * Dose Study Design Major Outcomes Reference
Diabetes
6.1% catechin, 6.78% epicatechin, 55.59% dimeric
forms, 11.91% trimeric forms, 6.55% tetrameric
forms and small amounts of other polymeric
forms
96.64% 500 mg/kg BW/day STZ-induced diabetic male Sprague–Dawleyrats with basal diet; GSPE (16 weeks)
The score of beta-cell function and the abnormal
oral glucose tolerance partially reversed, ↑
normal insulin content
[76]
Monomeric (21.3%), dimeric (17.4%), trimeric
(16.3%), tetrameric (13.3%) and oligomeric
(5–13 units; 31.7%)
>75% 25 mg/kg BW/day Diet-induced obese female Wistar rats; GSPE(10 days and 30 days)
↓ fasting plasma insulin levels after 10 and 30
days [72]
Monomeric (21.3%), dimeric (17.4%), trimeric
(16.3%), tetrameric (13.3%) and oligomeric
(5–13 units) (31.7%) procyanidins and phenolic
acids (4.7%)
NE 345 mg/kg BW/day HFD fed Male Zucker rats; GSPE (19 weeks) ↓ glucose levels [59]
89 % PAC, 6 % monomers, and 5 % other
materials NE 100 mg/kg BW/day
High fat-fructose diet fed male Wistar rats;
GSPE (45 days)
↓ glucose and insulin levels, ↑ insulin sensitivity,
restoration of the activities of glycolytic enzymes
in the liver
[81]
Flavan-3-ols (21.3%), dimers (17.4%), trimers
(16.3%), tetramers (13.3%) and oligomers
(5–13 units; 31.7%) of PAs
>75% 25, 100 and 200 mg/kg BW Diet-induced obese male Wistar rats; GSPE(12 weeks)
No significant changes in glucose, insulin or
HOMA-IR plasma levels [74]
Flavan-3-ols (21.3%), dimers (17.4%), trimers
(16.3%), tetramers (13.3%) and oligomers
(5–13 units; 31.7%) of PAs
>75% 25 mg/kg BW/day Diet-induced obese male Wistar rats; GSPE(3 weeks) ↓ plasma glucose and insulin levels [73]
Cardiovascular risk disease
Flavan-3-ols (21.3%), dimers (17.4%), trimers
(16.3%), tetramers (13.3%) and oligomers
(5–13 units; 31.7%) of procyanidins.
>75% 375 mg/kg BW Male, spontaneously hypertensive rats;GSPE (2 days) ↓ DBP and SBP [49]
NE 37% 100 mg/kg BW Hypercholesterolemic induced-male Wistarrats; GSPE (30 days)
↓ Tissue and serum cholesterol levels, LDL,
serum free fatty acids, serum TAGs and ↑ (p <
0.01) serum phospholipids and HDL.
[50]
Flavan-3-ols (21.3%), dimers (17.4%), trimers
(16.3%), tetramers (13.3%) and oligomers
(5–13 units; 31.7%) of PAs
>75% 25 mg/kg BW/day Diet-induced obese male Wistar rats; GSPE(3 weeks) ↓ TC [73]
Flavan-3-ols (21.3%), dimers (17.4%), trimers
(16.3%), tetramers (13.3%) and oligomers
(5–13 units; 31.7%) of PACs
>75% 345 mg/kg BW/day HFD fed Male Zucker rats; GSPE (19 weeks) No changes in total plasma cholesterol [59]
NE NE 150, 240,384 mg/kg BW/day
DOCA hypertension-induced SD rats; GSPE
(4 weeks)
↓ SBP, reversion of morphological hypertrophy
of heart, ↑ in aortic rings vasodilatation [51]
Flavan-3-ols (21.3%), dimers (17.4%), trimers
(16.3%), tetramers (13.3%) and oligomers
(5–13 units; 31.7%) of PACs
>75% 25, 100 and 200 mg/kg BW Diet-induced obese male Wistar rats; GSPE(12 weeks)
No significant changes in plasma TC, TAGs,
HDL [74]
Flavan-3-ols (21.3%), dimers (17.4%), trimers
(16.3%), tetramers (13.3%) and oligomers
(5–13 units; 31.7%) of PACs
>75% 500 mg/kg BW/day Diet-induced obese female Wistar rats; GSPEintermittently
No significant changes in plasma TAGs, fatty
acids and cholesterol levels [77]
* NE, non-specified; BAT, brown adipose tissue; BW, body weight; CART, Cocaine- and amphetamine-regulated transcript; DBP, diastolic blood pressure; GLP-1, glucagon-like peptide-1;
GSPE, grape seed proanthocyanidins extract; HDL, high-density lipoprotein; HFD, high-fat diet; HOMA-IR, homeostasis assessment model for insulin resistance; LDL, low-density
lipoprotein; Nrf2, Nuclear factor erythroid 2-related factor 2; PACs, proanthocyanidins; PPARΥ, Proliferator-activated receptor gamma; SBP, systolic blood pressure; TAGs, triglycerides;
TC, total cholesterol; WAT, white adipose tissue.
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Other authors, however, showed that the administration of 89% PACs-GSPE (100 mg/kg BW)
increased the insulin sensitivity measured by HOMA and QUICKI indices and decreased glucose
levels compared to HFD-feed rats but when they compared between treatments, they found that the
combination of GSPE and metformin had a better response than individual treatments [81]. The same
authors hypothesized that improvement in insulin signaling could be attributed to the reduction of
cytokines such as TNF-α and IL-6 in high fat-fructose diet fed Wistar rats when GSPE was administered
for 45 days [81].
Notwithstanding most of the experimental studies showed an improvement of glucose homeostasis
in animals, there is still no consensus on the chronic effects of proanthocyanidins on the maintenance
of whole-body glucose homeostasis as previously affirmed by Montagut et al. [72].
3.3.3. Cardiovascular Risk Disease
According to the WHO, more than 17 million people died from CVDs in 2016 which represent
around 31% of all global death (WHO, 2017). Accordingly, hypertension is one of the most important
risk factors for CVD being behavioral habits such as diet, sedentarism, and tobacco and alcohol intake
implicated in hypertension development. Once again, the diet is one of the essential pillars for the
prevention or amelioration of CVD. In this regard, the role of the GSPE has also been studied with very
promising results. Quiñones et al. [49] tested three different concentrations of a GSPE i.e., 250, 375 and
500 mg/kg BW in male, spontaneously hypertensive rats. They found a significant decrease in systolic
(SBP) and diastolic (DBP) blood pressure which was dose-dependent up to 375 mg/kg BW GSPE in
the case of SBP. Interestingly, the effect of the administration of 375 mg/kg BW GSPE in reducing
the SBP was similar than the administration of captopril 50 mg/kg BW. Contrarily, no significant
differences were found in normotensive Wistar–Kyoto rats supplemented with 375 mg/kg/BW GSPE
which suggest that GSPE could be used as treatment but could not have a preventive action against
hypertension [49]. Contrarily, Huang et al. showed protective effects against increase of blood pressure
in hypertension-induced rats [51]. Additionally, SBP was significantly reduced in rats treated with
GSPE as compared to DOCA-salt hypertensive rats from week 3 at doses of 150 mg/kg BW/day
and from week 1 at higher doses (240, 384 mg/kg BW/day) together with an increase in aortic rings
vasodilatation induced by acetylcholine and a suppression of endothelin-1 plasma and cardiac tissue
levels [51]. Remarkably, those effects were comparable with the intake of 5 mg/kg of amlodipine, a
specific drug employed for treating hypertension. However, even showing positive effects, the lack of
information about the extract composition, make difficult to compare with other studies in order to
determine the best composition of GSPE to treat CVDs.
It is known that oxidative stress also plays an important role in the CVD etiology in spite that
the direct mechanism of action is still being studied [82]. Some studies show that doses from 150
to 384 mg/kg BW/day GSPE increase SOD activities, inhibit the increase of serum and cardiac MDA
and also inhibit the p-JNK1/2 and p-p38MAPK expressions, mainly implicated in cardiomyocyte
hypertrophy [51,83].
On the other hand, hyperlipidemia, related to refer to elevated cholesterol, elevated TAGs or
both, is also pointed out as one of the CVD risks factor which is also closely related to the diet [84].
In this context, Thiruchenduran, et al. [50] showed that the administration of 100 mg/kg BW of
GSPE, with a purity of 37%, significantly reversed the serum cholesterol, LDL, free fatty acids and
TAGs levels while increased serum phospholipids and HDL concentration in experimentally induced
hypercholesterolemia Wistar rats. Additionally, the same authors found an amelioration in the activity
of diagnostic cardiac serum markers enzymes such as glutamate oxaloacetate transaminase (SGOT),
lactate dehydrogenase (LDH) and creatine kinase (CK) [50]. Lower doses (25 mg GSPE/kg BW) of GSPE
made up flavan-3-ols (21.3%), dimers (17.4%), trimers (16.3%), tetramers (13.3%) and oligomers (31.7%)
of PACs allowed a significant decreased of TC by around 20% but not in TAG or LDL in diet-induced
obese Wistar rats [73]. Surprisingly, the decreased TC plasma levels were observed when GSPE was
administered for 3 weeks [73] but not when the supplementation was for longer (12 weeks) [74]. This
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suggests that the time of the treatment could influence in a great manner the effect of the treatment.
Contrarily, higher doses (from 100 to 345 mg/kg BW/day) of the same GSP extract did not show any
significant change in TC, TAGs or HDL plasma levels when administered chronically, i.e., from 3 to
12 weeks [74] nor intermittently at even higher doses (500 mg/kg BW/day) [77].
Due to the controversial results, further research is necessaries to stablish a cause-effect relationship
between the administration of GSPE and the prevention or amelioration of CVD risks. It is noteworthy
to mention that, even most studies employed similar doses of GSPE, the difference between results
might be due to the different composition of the grape seed extracts in PACs. In fact, despite most of
the studies administered commercial extracts, some others employed in-house extracts without an in
deep characterization of the PAC content [50], thus, making difficult the comparison between them.
4. Conclusions
The interest of natural products to treat and/or prevent chronic diseases is increasing. In this
regard, much evidence, both, in vitro and in animal models has been accumulated regarding the
relationship between the antioxidant effect of natural products and the development of chronic diseases.
In fact, a large number of research studies have demonstrated a broad spectrum of pharmacological
and therapeutic benefits of GSPE. Indeed, is undeniable that PACs from grape seeds are highly
antioxidants. Accordingly, since oxidative stress, inflammation process and MeS-related pathologies
are connected somehow, GSPE bioactivity could be mainly mediated by its antioxidant activity.
However, contradictory conclusions resulted from the use of different animal species, small sample size,
different GSPE doses and duration of the studies make complicated to stablish the real bioactive effect
of GSPE on health. In this regard, the standardization of the dosage and the composition of the extracts
is a necessity to shed light into the cause-effect relationship between the intake of PACs from grape
seeds and their health effects in a more accurate way. It should not be forgotten that the synergistic
effect of GSPE and other already employed drugs should be noteworthy and further studied.
Despite GSPE have proven to be a promising natural extract with multiple health benefits in
in vivo animal studies, further well-design clinical trials are necessaries to confirm the beneficial effects
of GSPE on oxidative stress, inflammation and MeS-related pathologies such as obesity, diabetes and
CVD in humans.
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